ゲノム編集市場：技術、用途、エンドユーザー別-2025-2030年の世界予測

ゲノム編集市場は、2023年に108億米ドルと評価され、2024年には165億4,000万米ドルに達すると予測され、CAGR 53.22％で成長し、2030年には2,142億2,000万米ドルになると予測されています。

生物のDNAを改変する科学的アプローチであるゲノム編集は、農業からヘルスケアまで幅広い用途で大きな支持を得ています。この技術は、特定の望ましい形質を持つ遺伝子組み換え生物を作り出す能力において極めて重要であり、農作物における耐病性やヘルスケアにおける治療法開発の進展といった問題に対処しています。ゲノム編集の必要性は、正確で費用対効果の高い遺伝子組み換えを可能にすることで、食糧安全保障や遺伝性疾患などの差し迫った世界の問題を解決できる可能性に由来します。その主な用途は、害虫に強く収量の多い作物を開発するための農業分野と、遺伝子疾患を治療するための遺伝子治療を中心としたヘルスケア分野です。さらに、バイオ燃料生産と環境技術のための産業バイオテクノロジーでも飛躍的な進歩を遂げています。

ゲノム編集の市場成長は、主に高度な治療ソリューションに対する需要の増加、バイオテクノロジーの継続的な進歩、遺伝病に対する理解の深まりによってもたらされます。最新のビジネスチャンスとしては、治療薬におけるCRISPRアプリケーションの拡大や、持続可能で弾力性のある食糧システムをサポートするための作物改良プログラムが挙げられます。研究機関への投資や提携を行う企業は、ゲノム編集における特許取得可能な新技術を活用し、規制当局の承認を得て、新興市場への早期参入を実現することができます。企業に対する主な提言は、より精度が高く、オフターゲット効果の少ない遺伝子編集ツールの開発と、研究開発能力を強化するためのパートナーシップの拡大に注力することであろう。

しかし、遺伝子改変に対する倫理的懸念、厳しい規制環境、市場導入に影響を及ぼす潜在的な社会経済的格差など、市場は大きな課題に直面しています。一般市民の認識や倫理的な議論は、地域によっては技術の受容を制限する可能性があり、透明性のあるコミュニケーションや地域社会への関与の取り組みが必要となります。イノベーションは、ベースエディターのような次世代編集ツールの開発、治療応用のための送達メカニズムの改善、政策立案者との積極的な対話による規制上のボトルネックへの対処に焦点を当てるべきです。ゲノム編集市場は急速な技術進化を特徴としており、倫理的・規制的状況を巧みにナビゲートできれば、企業がイノベーションを起こすための肥沃な土壌を提供します。

市場力学：急速に進化するゲノム編集市場の主要市場インサイトを公開

ゲノム編集市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 政府資金の増加とゲノミクス・プロジェクト数の増加
  • ゲノミクスの応用分野の拡大
  • 感染症やがんの高蔓延
  • 遺伝子組み換え作物の生産増加
• 市場抑制要因
  • 訓練を受けた専門家の不足
  • 遺伝子調査に対する社会的評価の低下
• 市場機会
  • 専門医療におけるゲノム編集の使用
  • CRISPR-Cas9システムによるゲノム編集の進歩
• 市場の課題
  • ゲノム解析機器の高コスト
  • 大量のシーケンスデータの安全な保管

ポーターの5つの力：ゲノム編集市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ゲノム編集市場における外部からの影響の把握

外部マクロ環境要因は、ゲノム編集市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ゲノム編集市場における競合情勢の把握

ゲノム編集市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスゲノム編集市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ゲノム編集市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ゲノム編集市場における成功への道筋を描く

ゲノム編集市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 政府資金の増加とゲノミクスプロジェクト数の増加
    • ゲノミクスの応用分野の拡大
    • 感染症とがんの蔓延率が高い
    • 遺伝子組み換え作物の生産増加
  • 抑制要因
    • 訓練を受けた専門家の数が限られている
    • 遺伝子調査に対する国民の否定的な認識
  • 機会
    • 専門医療におけるゲノム編集の使用
    • CRISPR-Cas9システムによるゲノム編集の進歩
  • 課題
    • ゲノミクス機器に関連する高コスト
    • 大量のシーケンスデータの安全な保存
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ゲノム編集市場：技術別

• アンチセンス
• クリスパー
• タレン
• ジンクフィンガーヌクレアーゼ

第7章 ゲノム編集市場：用途別

• 細胞株エンジニアリング
• 遺伝子工学
  • 動物遺伝子工学
  • 植物遺伝子工学

第8章 ゲノム編集市場：エンドユーザー別

• 学術機関および政府調査機関
• バイオテクノロジーおよび製薬会社
• 契約調査機関

第9章 南北アメリカのゲノム編集市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のゲノム編集市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのゲノム編集市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abcam PLC
• AgriGenome Labs Pvt. Ltd.
• Beam Therapeutics Inc.
• Biocompare, Inc.
• Danaher Corporation
• Editas Medicine, Inc.
• GenScript Biotech Corporation
• Lonza Group AG
• Merck KGaA
• OriGene Technologies, Inc.
• PerkinElmer Inc.
• Regeneron Pharmaceuticals, Inc.
• Sangamo Therapeutics, Inc.
• Thermo Fisher Scientific Inc.
• Verve Therapeutics, Inc.

LIST OF FIGURES

• FIGURE 1. GENOME EDITING MARKET RESEARCH PROCESS
• FIGURE 2. GENOME EDITING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENOME EDITING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENOME EDITING MARKET DYNAMICS
• TABLE 7. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENOME EDITING MARKET SIZE, BY ANTISENSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENOME EDITING MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENOME EDITING MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENOME EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENOME EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENOME EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENOME EDITING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. CANADA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 38. CANADA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. CHINA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. CHINA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 60. CHINA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. INDIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. INDIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 64. INDIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. ITALY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. ITALY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 133. ITALY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. POLAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. POLAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 149. POLAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. QATAR GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. QATAR GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 153. QATAR GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023

The Genome Editing Market was valued at USD 10.80 billion in 2023, expected to reach USD 16.54 billion in 2024, and is projected to grow at a CAGR of 53.22%, to USD 214.22 billion by 2030.

Genome editing, the scientific approach to modifying an organism's DNA, has gained significant traction in applications ranging from agriculture to health care. This technology is pivotal for its ability to create genetically modified organisms with specific desired traits, addressing issues such as disease resistance in crops and advancing therapeutic development in healthcare. The necessity of genome editing stems from its potential to solve pressing global issues, including food security and genetic disorders, by enabling precise and cost-effective genetic modifications. Its primary applications are in agriculture, for developing pest-resistant and higher-yield crops, and in healthcare, particularly in gene therapy to treat genetic conditions. Additionally, it's making strides in industrial biotechnology for biofuel production and environmental technology.

Market growth in genome editing is primarily driven by increasing demand for advanced therapeutic solutions, continuous advancements in biotechnology, and a growing understanding of genetic diseases. The latest opportunities include expanding CRISPR applications in therapeutics and crop improvement programs to support sustainable and resilient food systems. Companies that invest in and partner with research institutions can leverage new patentable techniques in genome editing, gain regulatory approvals, and achieve early entry into emerging markets. Key recommendations for businesses would be to focus on developing gene editing tools with higher accuracy and fewer off-target effects, and the expansion of partnerships to enhance R&D capabilities.

However, the market faces significant challenges such as ethical concerns over genetic modifications, stringent regulatory environments, and potential socio-economic disparities impacting market adoption. Public perception and ethical debates could limit technology acceptance in some regions, necessitating transparent communication and community engagement initiatives. Innovation should focus on creating next-gen editing tools like base editors, improving delivery mechanisms for therapeutic applications, and addressing regulatory bottlenecks through proactive dialogue with policymakers. The genome editing market is characterized by rapid technological evolution, offering a fertile ground for businesses to innovate, provided they navigate ethical and regulatory landscapes adeptly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genome Editing Market

The Genome Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising government funding and growth in the number of genomics Projects
  • Growing application areas of genomics
  • High prevalence of infectious diseases and cancer
  • Increasing production of genetically modified crops
• Market Restraints
  • Limited availability of trained professionals
  • Adverse public perception of genetic research
• Market Opportunities
  • Use of genome editing in specialized medicine
  • Advancements in genome editing with CRISPR-Cas9 system
• Market Challenges
  • High cost associated with genomics equipment
  • Secure storage of large volumes of sequenced data

Porter's Five Forces: A Strategic Tool for Navigating the Genome Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genome Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genome Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genome Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genome Editing Market

A detailed market share analysis in the Genome Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genome Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genome Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genome Editing Market

A strategic analysis of the Genome Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genome Editing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, AgriGenome Labs Pvt. Ltd., Beam Therapeutics Inc., Biocompare, Inc., Danaher Corporation, Editas Medicine, Inc., GenScript Biotech Corporation, Lonza Group AG, Merck KGaA, OriGene Technologies, Inc., PerkinElmer Inc., Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc., Thermo Fisher Scientific Inc., and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the Genome Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Antisense, CRISPR, Talen, and Zinc Finger Nucleases.
• Based on Application, market is studied across Cell Line Engineering and Genetic Engineering. The Genetic Engineering is further studied across Animal Genetic Engineering and Plant Genetic Engineering.
• Based on End User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising government funding and growth in the number of genomics Projects
    • 5.1.1.2. Growing application areas of genomics
    • 5.1.1.3. High prevalence of infectious diseases and cancer
    • 5.1.1.4. Increasing production of genetically modified crops
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of trained professionals
    • 5.1.2.2. Adverse public perception of genetic research
  • 5.1.3. Opportunities
    • 5.1.3.1. Use of genome editing in specialized medicine
    • 5.1.3.2. Advancements in genome editing with CRISPR-Cas9 system
  • 5.1.4. Challenges
    • 5.1.4.1. High cost associated with genomics equipment
    • 5.1.4.2. Secure storage of large volumes of sequenced data
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genome Editing Market, by Technology

• 6.1. Introduction
• 6.2. Antisense
• 6.3. CRISPR
• 6.4. Talen
• 6.5. Zinc Finger Nucleases

7. Genome Editing Market, by Application

• 7.1. Introduction
• 7.2. Cell Line Engineering
• 7.3. Genetic Engineering
  • 7.3.1. Animal Genetic Engineering
  • 7.3.2. Plant Genetic Engineering

8. Genome Editing Market, by End User

• 8.1. Introduction
• 8.2. Academic & Government Research Institutes
• 8.3. Biotechnology & Pharmaceutical Companies
• 8.4. Contract Research Organizations

9. Americas Genome Editing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Genome Editing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Genome Editing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. AgriGenome Labs Pvt. Ltd.
• 3. Beam Therapeutics Inc.
• 4. Biocompare, Inc.
• 5. Danaher Corporation
• 6. Editas Medicine, Inc.
• 7. GenScript Biotech Corporation
• 8. Lonza Group AG
• 9. Merck KGaA
• 10. OriGene Technologies, Inc.
• 11. PerkinElmer Inc.
• 12. Regeneron Pharmaceuticals, Inc.
• 13. Sangamo Therapeutics, Inc.
• 14. Thermo Fisher Scientific Inc.
• 15. Verve Therapeutics, Inc.